National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

metoprine
A diaminopyrimidine folate antagonist with potential antineoplastic activity. Metoprine inhibits dihydrofolate reductase, resulting in decreased cellular folate metabolism and cell growth; it also inhibits histamine-N-methyltransferase, resulting in decreased histamine catabolism. Lipid-soluble metoprine is capable of crossing the blood-brain barrier. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:DDMP
Code name:BW 197U



Previous:methylphenidate hydrochloride, methylprednisolone, Meti-derm, Meticorten, metoclopramide hydrochloride
Next:Metro I.V., Metrocort, metronidazole hydrochloride, Metypred, metyrosine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov